Study identifies a potential treatment for Sandhoff and Tay-Sachs diseases

In a groundbreaking study, researchers at McMaster University have identified a potential treatment for Sandhoff and Tay-Sachs diseases—two rare, often fatal lysosomal storage disorders that cause progressive damage to nerve cells in the brain and spinal cord.

Bedfont Scientific Ltd. and NewMed Ltd. Proudly Raise Over £28,000 in Funds for Heart of Kent Hospice

August 6, 2024

FDA clears IND for Biora Therapeutics’s ulcerative colitis drug – Pharmaceutical Technology

Share this article Biora Therapeurics is preparing an ulcerative colitis therapy. Credit: Emily frost via Shutterstock. The US Food and Drug Administration (FDA) cleared Biora

December 1, 2023

Emphasizing workforce diversity in the One Health approach

A new article highlights a critical issue in the One Health approach-;an emerging global framework for tackling complex health challenges at the intersection of human,

October 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.